Skip to main navigation
Skip to main content
Skip to page footer
Back
Nostos Genomics GmbH
Nostos Genomics develops AION, an AI-driven genetic variant interpretation platform that accelerates the diagnostic process for rare diseases to under 30 minutes per exome. The CE-certified white-box software combines machine learning with synthetic biology data to classify and prioritize disease-causing mutations with >93% sensitivity. Target users include genetic testing laboratories, hospitals, and clinical research institutions.
